Pharmaceuticals & Medical Devices

We provide economic analysis, expert testimony, and regulatory insight to support all phases of litigation pertaining to the pharmaceutical and medical device industries.

Brattle’s pharmaceutical and medical device industry experts have a proven track record of successful case execution for our clients. We have decades of experience working on cases involving the key issues in these industries, including antitrust matters, patent disputes, and contract litigation. We have principals who regularly testify in these matters, as well as close working relationships with leading academic experts and experienced practitioners in these industries.

Brattle provides its clients with rigorous analysis while managing costs carefully in order to deliver the maximum net value to our clients. We are known for our close working relationships with leading academics and practitioners and for the clear and successful communication of economic and financial reasoning to clients, judges, juries, and other decision makers.

Areas of Expertise

Cameron 063
Dr. Lisa Cameron is an economist with two decades of experience consulting to attorneys and companies involved in commercial litigation, regulatory proceedings, and other complex matters. More icon f02782c24cccaf6d90e1da53920c42f20e5a8955f54ac2ca5727ec7dc89987b4
Neels 241
Dr. Neels has more than 30 years of research and consulting experience in all aspects of the transportation sector. More icon f02782c24cccaf6d90e1da53920c42f20e5a8955f54ac2ca5727ec7dc89987b4
Principal Emeritus
Principal Emeritus
Dr. Reynolds is widely known for his empirical and theoretical analyses of antitrust, regulatory, and financial issues. More icon f02782c24cccaf6d90e1da53920c42f20e5a8955f54ac2ca5727ec7dc89987b4
Academic Advisors
Academic Advisor
Dr. Bowblis is an Associate Professor in the Department of Economics at Miami University, where he teaches courses in health economics, antitrust, industrial organization, econometrics, and the economics of regulation. More icon f02782c24cccaf6d90e1da53920c42f20e5a8955f54ac2ca5727ec7dc89987b4
Academic Advisor
Dana Goldman is a Professor and the Norman Topping Chair in Medicine and Public Policy at the University of Southern California. More icon f02782c24cccaf6d90e1da53920c42f20e5a8955f54ac2ca5727ec7dc89987b4
Academic Advisor
Dr. Grabowski is a Professor of Economics, member of the faculty for the Health Sector Management Program, and Director of the Program in Pharmaceuticals and Health Economics at Duke University. More icon f02782c24cccaf6d90e1da53920c42f20e5a8955f54ac2ca5727ec7dc89987b4
May 10, 2016
Prepared for the United States Court of Appeals for the Third Circuit
Antitrust Analysis in Physician, Hospital, and Insurer Matters
Published by The Brattle Group, Inc.
An empirical analysis of the multimarket contact theory in pharmaceutical markets
July 2013
Pedro L. Marin, Javier Coronado, and Sergi Jimenez-Martin
Published in The European Journal of Health Economics